tiprankstipranks
Apellis announces pegcetacoplan MAA review has been reset to Day 180
PremiumThe FlyApellis announces pegcetacoplan MAA review has been reset to Day 180
8d ago
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
PremiumPress Releases
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
11d ago
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29d ago
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress ReleasesApellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
2M ago
Apellis expects cash to fund expenditures for ‘foreseeable future’
PremiumThe Fly
Apellis expects cash to fund expenditures for ‘foreseeable future’
2M ago
Apellis reports Q4 EPS (73c), consensus (69c)
PremiumThe Fly
Apellis reports Q4 EPS (73c), consensus (69c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100